BioInvent Announces Publication of Data in Leading Cancer Journal Immunity

Go back to BioInvent Announces Publication of Data in Leading Cancer Journal Immunity
(NYSE: BINV) Delayed: 45.95 +0.46 (1.01%)
Previous Close $45.49    52 Week High
Open $45.97    52 Week Low
Day High $46.05    P/E N/A 
Day Low $45.82    EPS
Volume 19,093